Transdermal composition
AssigneeInBold Inc.
InventorsKenda HANSEN, Kathleen GRAVE
Life of this patent
Estimating the term…
Loading patent…
AssigneeInBold Inc.
InventorsKenda HANSEN, Kathleen GRAVE
Estimating the term…
A formulation include a cannabinoid extract that is pharmaceutically effective via topical application. A unit dose having a cannabinoid component in the range of from I milligram to 100 milligram is included within an oil or other solution sourced from the same plant or same type of plant from which the cannabinoid component is sourced, another cannabinoid-producing plant, and/or one or more suitable oils known in the art. One version contains the cannabinoid extract provided in a unit dose within the range by volume of a pharmaceutically-active composition of from less than 0.3 milliliter to 3.0 milliliter that contains a cannabinoid component preferably in the range of from 1 milligram to 100 milligram. The unit dose may include Jojoba oil, dimethyl sulfoxide, bromelain, olive oil, fulvic acid, and/or Vitis vinifera seed oil.
-24. (canceled)
A transdermal pharmaceutical composition for delivery of at least one cannabinoid into the systemic circulation of a subject comprising:
A transdermal pharmaceutical composition for delivery of cannabinoid into the systemic circulation of a subject comprising:
A method for treating chronic pain in a subject in need thereof, comprising applying an effective amount of a transdermal pharmaceutical composition to the skin of said subject, wherein the transdermal pharmaceutical composition comprises:
Dependencies are inferred from the claim text.